<?xml version="1.0" encoding="UTF-8"?>
<p>Management of COVID-19 infection aims first to ameliorate clinical manifestations and to provide supportive care [
 <xref rid="B48-ijms-21-05145" ref-type="bibr">48</xref>]. Nevertheless, long-term experimentation may be necessary for researchers to develop, produce, standardize, assess, and commercialize novel drugs specific to the novel virus.
</p>
